Search

everythinglearnresearchcommunity

for

Search:↓

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Proscar (finasteride) blocks 5α-reductase in sea urchin ovaries and testes, suggesting potential treatment for androgen-related conditions.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Overexpression of SSAT causes hair loss and skin issues, but reducing putrescine can help.

Baricitinib is the most effective treatment for alopecia areata.

Dermal EZH2 controls skin cell development and hair growth in mice.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

The treatment was ineffective in humans.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

JAK inhibitors might help treat alopecia areata.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

P-3074 effectively blocks scalp DHT better than oral finasteride.

The retinoid receptor antagonist effectively disrupts vitamin A-related development in embryos.

Early sunburn treatment with certain inhibitors may reduce skin cancer risk.

The traditional herbal formulas Yongdamsagan-Tang and Paljung-san, along with the drug finasteride, can reduce inflammation and may work together without affecting each other's effectiveness against benign prostatic hyperplasia.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Abnormal activation of hair follicle stem cells and Wnt/β-catenin signaling contributes to sebaceous neoplasms.

Removing both KLK5 and KLK7 proteins can prevent death and skin issues in Netherton syndrome.

EETs can delay seizures by affecting GABA activity, offering potential new treatments for seizures.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

Tadalafil and Finasteride may help treat aggressive melanoma.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.